China
2026.11.19 00:03 GMT+8

Zambia breaks ground on its first vaccine manufacturing plant

Updated 2026.11.19 00:04 GMT+8
CGTN Africa

Zambia has taken a major step towards vaccine self-reliance and strengthening public health security following the groundbreaking ceremony for the ZamVax Vaccine Manufacturing Facility at the Multi-Facility Economic Zone (MFEZ) in Lusaka, November 17, 2026. /Ministry of Health in Zambia

Zambia has officially broken ground on its first vaccine manufacturing plant in the capital, Lusaka, marking a major milestone in efforts to boost domestic vaccine production and strengthen long-term health security.

Located in the Lusaka South Multi-Facility Economic Zone, the facility is being developed by ZAMVAX, a joint venture between the Zambian government's Industrial Development Corporation (IDC) and China's Jijia International Medical Technology Company Limited, with a 60–40 equity split.

The groundbreaking ceremony brought together Zambia's Minister of Health Roma Chilengi, Minister Counsellor at the Chinese Embassy in Zambia Wang Sheng, senior government officials and executives from the Chinese company involved in the project.

In its first phase, the plant will operate as a fill-and-finish facility for oral cholera vaccines, with an annual production capacity of approximately 20 million doses.

The second phase will introduce local antigen production, enabling Zambia to undertake end-to-end cholera vaccine manufacturing.

Over time, the facility is also expected to expand into the production of pediatric and veterinary vaccines.

Zambia marked a major step towards vaccine self-reliance and stronger public health security with the groundbreaking ceremony for the ZamVax Vaccine Manufacturing Facility at the Multi-Facility Economic Zone (MFEZ) in Lusaka, Zambia, on November 17, 2026. /Ministry of Health in Zambia

Copyright © 

RELATED STORIES